Skip to main content

Table 2 Treatment responses at day 28 after PCR correction for the first episode in the intent-to-treat patient populationa

From: Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

Treatment response

ASAQ

AL

Total

 

Number (%)

Overall population

(n = 184)

(n = 182)

(n = 366)

   Late clinical failure

0 (0.0)

3 (1.6)

3 (0.8)

   Late parasitological failure

1 (0.5)

2 (1.1)

3 (0.8)

   Adequate clinical and parasitological response

181 (98.4)

175 (96.2)

356 (97.3)

   Not applicable

2 (1.1)

2 (1.1)

4 (1.1)

<12 years old

(n = 101)

(n = 100)

(n = 201)

   Late clinical failure

0 (0.0)

3 (3.0)

3 (1.5)

   Late parasitological failure

1 (1.0)

1 (1.0)

2 (1.0)

   Adequate clinical and parasitological response

98 (97.0)

95 (95.0)

293 (96.0)

   Not applicable

2 (2.0)

1 (1.0)

3 (1.5)

12 years old

(n = 83)

(n = 82)

(n = 165)

   Late parasitological failure

0 (0.0)

1 (1.2)

1 (0.6)

   Adequate clinical and parasitological response

83 (100.0)

80 (97.6)

163 (98.8)

   Not applicable

0 (0.0)

1 (1.2)

1 (0.6)

  1. aAll randomized patients receiving at least one dose of study drug (patients vomiting twice after receipt of first dose were excluded).